Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details-
Title Grant Type Focus Area Country Application Due Date Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast CancerRelease Date:Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophiliaRelease Date:Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease RegistryRelease Date:Research Inflammation & Immunology Germany Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia InfectionsRelease Date:Research Inflammation & Immunology China Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Advancing Multidisciplinary Care in HemophiliaRelease Date:Quality Improvement Rare Disease China BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA -
Title Grant Type Focus Area Country Application Due Date Implementation of Telemedicine in Inflammatory Conditions: A Quality Improvement RFPRelease Date:Quality Improvement Inflammation & Immunology Canada, USA ADVANCE: Global Awards for Advancing Chronic Pain ResearchResearch Internal Medicine All Improving Disparities in Ulcerative Colitis Health Care in Post COVID-19 EraRelease Date:Quality Improvement Inflammation & Immunology United Kingdom New Guidelines for Immuno-therapy in Urothelial Carcinoma (UC)Release Date:Partner: Merck KGaA Darmstadt, Germany and EMD SeronoEducation Oncology France, Germany, Italy, Spain, USA, United Kingdom Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia AreataRelease Date:Education Inflammation & Immunology USA PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology All Remote Mentoring Programs in RCCRelease Date:Education Oncology USA Quality of Care Improvement in Metastatic Breast Cancer Patients (Europe)Release Date:Partner: The Sharing Progress in Cancer Care (SPCC)Quality Improvement Oncology All Identifying and Diagnosing polyarticular Juvenile Idiopathic Arthritis (pJIA)Release Date:Education Inflammation & Immunology Canada, USA NSCLC Oncogene Driver Considerations in Testing & TreatmentRelease Date:Education Oncology USA Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision MakingRelease Date:Education Oncology Canada, USA Unmet Need and Burden of Disease in Moderate-to-Severe Alopecia AreataRelease Date:Education Inflammation & Immunology France, Germany